Skip to main content
Top
Published in: European Journal of Epidemiology 6/2009

01-06-2009 | Renal Diseases

Plasma homocysteine is adversely associated with glomerular filtration rate in asymptomatic black and white young adults: the Bogalusa heart study

Authors: Litao Ruan, Wei Chen, Sathanur R. Srinivasan, Jihua Xu, Ahmet Toprak, Gerald S. Berenson

Published in: European Journal of Epidemiology | Issue 6/2009

Login to get access

Abstract

That plasma homocysteine is elevated markedly in renal dysfunction is well recognized. But whether the increased homocysteine is an independent correlate of glomerular filtration rate, a marker of renal function, in asymptomatic younger individuals is not clear. The aim of this study was to determine the association between plasma homocysteine and renal function in a biracial (black–white) community-based cohort of asymptomatic young adults. Plasma homocysteine along with cardiovascular disease risk factor variables were measured in 805 white and 330 black subjects, ages 24–44 years, enrolled in the Bogalusa Heart Study. Modification of Diet in Renal Disease Study equation was used to calculate the estimated glomerular filtration rate (eGFR) from serum creatinine level. Males versus females showed higher homocysteine levels (8.83 ± 3.16 vs. 7.35 ± 2.84 μmol/L, p < 0.0001) and lower eGFR (99.1 ± 17.6 vs. 102.5 ± 21.0 mL/min/1.73 m2, p = 0.024). Whites versus blacks had lower eGFR (97.3 ± 18.0 vs. 110.0 ± 20.6 mL/min/1.73 m2, p < 0.0001). In a multivariate regression analysis that included age, race, sex, body mass index, blood pressure, lipoprotein variables, insulin resistance index and homocysteine, white race, age and homocysteine, in that order, were independently and negatively associated with eGFR. The odds ratio (95% confidence interval) of individuals in the homocysteine quintiles II, III, IV and V vs. I for having the risk of impaired eGFR defined as <10th percentile was 2.28 (0.95–5.50, p = 0.065), 2.97 (1.24–7.12, p = 0.015), 3.32 (1.45–7.60, p = 0.005) and 6.99 (3.06–15.94, p < 0.0001), respectively. Homocysteine is an independent correlate of renal function in asymptomatic black and white young adults.
Literature
2.
4.
go back to reference Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003;108:2154–69. doi:10.1161/01.CIR.0000095676.90936.80.PubMedCrossRef Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003;108:2154–69. doi:10.​1161/​01.​CIR.​0000095676.​90936.​80.PubMedCrossRef
5.
go back to reference Bostom AG, Culleton BF. Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephrol. 1999;10:891–900.PubMed Bostom AG, Culleton BF. Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephrol. 1999;10:891–900.PubMed
6.
go back to reference Friedman AN, Bostom AG, Selhub J, Levey AS, Rosenberg IH. The kidney and homocysteine metabolism. J Am Soc Nephrol. 2001;12:2181–9.PubMed Friedman AN, Bostom AG, Selhub J, Levey AS, Rosenberg IH. The kidney and homocysteine metabolism. J Am Soc Nephrol. 2001;12:2181–9.PubMed
8.
go back to reference Samuelsson O, Lee DM, Attman PO, et al. The plasma levels of homocysteine are elevated in moderate renal insufficiency but do not predict the rate of progression. Nephron. 1999;82:306–11. doi:10.1159/000045445.PubMedCrossRef Samuelsson O, Lee DM, Attman PO, et al. The plasma levels of homocysteine are elevated in moderate renal insufficiency but do not predict the rate of progression. Nephron. 1999;82:306–11. doi:10.​1159/​000045445.PubMedCrossRef
11.
go back to reference Schäfer SA, Müssig K, Stefan N, Häring HU, Fritsche A, Balletshofer BM. Plasma homocysteine concentrations in young individuals at increased risk of type 2 diabetes are associated with subtle differences in glomerular filtration rate but not with insulin resistance. Exp Clin Endocrinol Diabetes. 2006;114:306–9. doi:10.1055/s-2006-924073.PubMedCrossRef Schäfer SA, Müssig K, Stefan N, Häring HU, Fritsche A, Balletshofer BM. Plasma homocysteine concentrations in young individuals at increased risk of type 2 diabetes are associated with subtle differences in glomerular filtration rate but not with insulin resistance. Exp Clin Endocrinol Diabetes. 2006;114:306–9. doi:10.​1055/​s-2006-924073.PubMedCrossRef
12.
go back to reference Robles NR, Sanchez Munoz-Torrero JF, Garcia Gallego F, Velasco Gemio J, Escola JM. Homocysteinemia in hypertensive patients with renal target organ damage (mild renal dysfunction). Eur J Med Res. 2008;13:196–9.PubMed Robles NR, Sanchez Munoz-Torrero JF, Garcia Gallego F, Velasco Gemio J, Escola JM. Homocysteinemia in hypertensive patients with renal target organ damage (mild renal dysfunction). Eur J Med Res. 2008;13:196–9.PubMed
13.
14.
go back to reference Berenson GS, McMahan CA, Voors AW, Webber LS, Srinivasan SR, Frank GC, et al. In: Andrews C, Hester HE, editors. Cardiovascular risk factors in children—the early natural history of atherosclerosis and essential hypertension. New York: Oxford University Press; 1980. p. 47–123. Berenson GS, McMahan CA, Voors AW, Webber LS, Srinivasan SR, Frank GC, et al. In: Andrews C, Hester HE, editors. Cardiovascular risk factors in children—the early natural history of atherosclerosis and essential hypertension. New York: Oxford University Press; 1980. p. 47–123.
15.
go back to reference Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem. 1995;41:991–4.PubMed Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem. 1995;41:991–4.PubMed
16.
go back to reference Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470–4.PubMed Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470–4.PubMed
17.
go back to reference Srinivasan SR, Berenson GS. Serum lipoproteins in children and methods for study. In: Lewis LA, editor. CRC handbook of electrophoresis vol III: lipoprotein methodology and human studies. Boca Raton, FL: CRC Press; 1983. p. 185–203. Srinivasan SR, Berenson GS. Serum lipoproteins in children and methods for study. In: Lewis LA, editor. CRC handbook of electrophoresis vol III: lipoprotein methodology and human studies. Boca Raton, FL: CRC Press; 1983. p. 185–203.
18.
go back to reference Levey AS, Coresh J, Balk E, et al. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–47.PubMed Levey AS, Coresh J, Balk E, et al. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–47.PubMed
19.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9. doi:10.1007/BF00280883.PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9. doi:10.​1007/​BF00280883.PubMedCrossRef
22.
go back to reference Brattström L, Lindgren A, Israelsson B, Andersson A, Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med. 1994;236:633–41.PubMedCrossRef Brattström L, Lindgren A, Israelsson B, Andersson A, Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med. 1994;236:633–41.PubMedCrossRef
25.
go back to reference Werstuck GH, Lentz SR, Dayal S, et al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest. 2001;107:1263–73. doi:10.1172/JCI11596.PubMedCrossRef Werstuck GH, Lentz SR, Dayal S, et al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest. 2001;107:1263–73. doi:10.​1172/​JCI11596.PubMedCrossRef
26.
go back to reference Outinen PA, Sood SK, Pfeifer SI, et al. Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. Blood. 1999;94:959–67.PubMed Outinen PA, Sood SK, Pfeifer SI, et al. Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. Blood. 1999;94:959–67.PubMed
27.
go back to reference Jakubowski H. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J. 1999;13:2277–83.PubMed Jakubowski H. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J. 1999;13:2277–83.PubMed
30.
go back to reference Jager A, Kostense PJ, Nijpels G, et al. Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study. Arterioscler Thromb Vasc Biol. 2001;21:74–81.PubMed Jager A, Kostense PJ, Nijpels G, et al. Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study. Arterioscler Thromb Vasc Biol. 2001;21:74–81.PubMed
31.
go back to reference Shankar A, Wang JJ, Chua B, Rochtchina E, Flood V, Mitchell P. Positive association between plasma homocysteine level and chronic kidney disease. Kidney Blood Press Res. 2008;31:55–62. doi:10.1159/000114300.PubMedCrossRef Shankar A, Wang JJ, Chua B, Rochtchina E, Flood V, Mitchell P. Positive association between plasma homocysteine level and chronic kidney disease. Kidney Blood Press Res. 2008;31:55–62. doi:10.​1159/​000114300.PubMedCrossRef
32.
go back to reference Astor BC, Hallan SI, Miller ERIII, Yeung E, Coresh J. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol. 2008;167:1226–34. doi:10.1093/aje/kwn033.PubMedCrossRef Astor BC, Hallan SI, Miller ERIII, Yeung E, Coresh J. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol. 2008;167:1226–34. doi:10.​1093/​aje/​kwn033.PubMedCrossRef
36.
go back to reference Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7–9.PubMed Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7–9.PubMed
37.
go back to reference Verhoef P, Stampfer MJ, Buring JE, et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol. 1996;143:845–59.PubMed Verhoef P, Stampfer MJ, Buring JE, et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol. 1996;143:845–59.PubMed
Metadata
Title
Plasma homocysteine is adversely associated with glomerular filtration rate in asymptomatic black and white young adults: the Bogalusa heart study
Authors
Litao Ruan
Wei Chen
Sathanur R. Srinivasan
Jihua Xu
Ahmet Toprak
Gerald S. Berenson
Publication date
01-06-2009
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 6/2009
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-009-9340-0

Other articles of this Issue 6/2009

European Journal of Epidemiology 6/2009 Go to the issue